Menu
Facilities
Careers
Newsroom
Resources
Blogs
Facilities
Careers
Newsroom
Resources
Blogs
Office Hour : 08:00am - 6:00pm
About Us
About Cohance
Purpose, Values & Promise
Leadership
Quality, Regulatory & Compliance
Science & Technology
Small Molecule API
API Development
API Manufacturing
ADCs
Integrated CRDMO
ADC Payloads
Nucleic Acid Chemistry
Nucleosides & Phosphoramidites Development
Nucleosides & Phosphoramidites Manufacturing
Products
Generic APIs
Product List
Specialty Chemicals
Agrochemicals
Investors
Financial Info
Shareholder Info
Corporate Governance
Corporate Info
Disclosure under Reg 46 of SEBI LODR
Sustainability
Our ESG Commitment
Sustainability in Action
Our ESG Aspirations
ESG Profile
Policies
Reports
Corporate Social Responsibility
Global Presence
Events
Facilities
Careers
Newsroom
Resources
Blogs
Contact Us
About Us
About Cohance
Purpose, Values & Promise
Leadership
Quality, Regulatory & Compliance
Science & Technology
Small Molecule API
API Development
API Manufacturing
ADCs
Integrated CRDMO
ADC Payloads
Nucleic Acid Chemistry
Nucleosides & Phosphoramidites Development
Nucleosides & Phosphoramidites Manufacturing
Products
Generic APIs
Product List
Specialty Chemicals
Agrochemicals
Investors
Financial Info
Shareholder Info
Corporate Governance
Corporate Info
Disclosure under Reg 46 of SEBI LODR
Sustainability
Our ESG Commitment
Sustainability in Action
Our ESG Aspirations
ESG Profile
Policies
Reports
Corporate Social Responsibility
Global Presence
Events
Facilities
Careers
Newsroom
Resources
Blogs
Contact Us
Close
Contact Us
Press Releases
Cohance Lifesciences
:
Press Releases
Select Year
Top Stories
2025
2024
In The News
Press Releases
Events
3rd September 2026
Cohance Lifesciences advances its ADC strategy
VIEW DETAILS →
12th August 2025
Press Release_ Investment in cGMP Bioconjugation Suite at NJ Bio...
VIEW DETAILS →
29th July 2025
Cohance Lifesciences Appoints Yann D'Herve as CEO of CDMO Business
VIEW DETAILS →
7th December 2024
Suven to acquire controlling stake in NJ Bio, Inc., an ADC specialist ...
VIEW DETAILS →
19th September 2024
Suven Pharmaceuticals names Mr. Vivek Sharma as ExecutiveChairman ...
VIEW DETAILS →
About Us
About Cohance
Purpose, Values & Promise
Leadership
Quality, Regulatory & Compliance
Science & Technology
Small Molecule API
API Development
API Manufacturing
ADCs
Integrated CRDMO
ADC Payloads
Nucleic Acid Chemistry
Nucleosides & Phosphoramidites Development
Nucleosides & Phosphoramidites Manufacturing
Products
Generic APIs
Product List
Specialty Chemicals
Agrochemicals
Investors
Financial Info
Shareholder Info
Corporate Governance
Corporate Info
Disclosure under Reg 46 of SEBI LODR
Sustainability
Our ESG Commitment
Sustainability in Action
Our ESG Aspirations
ESG Profile
Policies
Reports
Corporate Social Responsibility
Global Presence
Events
Facilities
Careers
Newsroom
Resources
Blogs
Contact Us
Top
